Home Compare PFE vs VEND.OL
Stock Comparison · Comparison

Pfizer vs VEND.OL: Which Stock Looks Stronger in 2026?

VEND.OL holds the cleaner structural position, with growth as the main driver and valuation adding further support. Pfizer still leads on valuation and stability, which keeps the comparison from looking entirely one-sided. In the market, Pfizer carries the stronger setup — intact trend against VEND.OL's broken trend. That leaves a split case: the structural lead stays with VEND.OL, but the market is not currently confirming it.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

Most of the separation is still concentrated in growth.

Trajectory Similarity
0.57
Moderately similar
Peer-set rank: #5
within Pfizer Inc.'s functional peer set

This pair is matched through long-term financial trajectory similarity within the selected peer universe.

A moderate similarity means the pair is structurally comparable, but not a near-twin trajectory match.

Most of the shared profile comes through recent revenue growth and operating margin level.

Similarity drivers
recent revenue growthoperating margin level
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
PFE
Pfizer Inc.
42
Peer-Score
Signal qualityHigh
vs
VEND.OL
VEND.OL
49
Peer-Score
Signal qualityMedium

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

Score differences across key dimensions.

Dimension spread: PFE vs VEND.OL Profitability 12 25 Stability 48 32 Valuation 82 52 Growth 19 100 PFE VEND.OL
Gap Ranking
#1 Growth +81
#2 Valuation +30
#3 Stability +16
#4 Profitability +13
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for PFE and VEND.OL Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer PFEVEND.OL Relative valuation Structural strength

VEND.OL still looks cheaper, even though Pfizer Inc. remains structurally stronger.

Valuation position uses peer-relative PE percentile (idx_pct_pe) and Forward P/E where available.

Relative Position vs Comparable Companies
Growth
On growth, VEND.OL ranks near the top of the group; Pfizer Inc. sits in the weaker half.
Valuation
On valuation, the same pattern holds: both are strong, but Pfizer Inc. still leads clearly.
Growth — Dominant Gap
PFE
19
VEND.OL
100
Gap+81in favour of VEND.OL

One company is still expanding while the other is contracting, which creates a very wide growth split.

What keeps the gap from being one-sided

Absolute pricing still looks more supportive for Pfizer, with a forward P/E that is 14.9 turns lower there.

What this means for the comparison

The growth lead is clear, but pricing and valuation still pull in the other direction — the result holds, but not without friction.

Explore full peer positioning in AssetNext

Break down the PFE vs VEND.OL comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how PFE and VEND.OL each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.